Catalyst
          Slingshot members are tracking this event:
          
        EyeGate (EYEG) Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance 
        
  | 
      Impact on Stocks
         | 
    ||||
|---|---|---|---|---|---|---|
| EYEG | 
             | 
          
  | 
          ||||
Additional Information
Slingshot Insights Explained
          
            Catalyst Date
          
            
                Occurred on: 
    Feb 05, 2018
 
 
          
          
    Related Projects 
      
  
  - 
          
Don’t see a project related to the catalyst you care about?
 
            Related Keywords
            
    Phase 2b Data, Egp-437, Cataract Surgery